Philip Mack

10PUBLICATIONS
85CO-AUTHORS
Molecular targetsPredictive and prognostic markersMedical biotechnology diagnostics (incl. biosensors)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 03, 2026
Resistance to Immune Checkpoint Inhibitor Treatment in Non-Small Cell Lung Cancer Clinical Trials: A Perspective From Lung-MAP Investigators.

|Jun 04, 2025
Elevated ctDNA Tumor Fraction Is Associated with Improved Mutation Detection but Worse Overall Survival in Advanced Non-Small Cell Lung Cancer: A Lung-MAP Study.

Philip C Mack, Mary W Redman, Hanna Tukachinsky

|Jul 27, 2024
Time-Dependent Effects of Clinical Interventions on SARS-CoV-2 Immunity in Patients with Lung Cancer.

Philip C Mack, Chih-Yuan Hsu, Ananda M Rodilla

|May 24, 2024
Multi-cancer early detection (MCED) tests: prioritizing equity from bench to bedside.

Sarah J Miller, Jamilia R Sly, Christian Rolfo

|May 26, 2023
Phase II Study of Docetaxel and Trametinib in Patients with KRAS Mutation Positive Recurrent Non-Small Cell Lung Cancer (NSCLC; SWOG S1507, NCT-02642042).

Shirish M Gadgeel, Jieling Miao, Jonathan W Riess

|Sep 07, 2022
A Genomically and Clinically Annotated Patient-Derived Xenograft Resource for Preclinical Research in Non-Small Cell Lung Cancer.

Xing Yi Woo, Anuj Srivastava, Philip C Mack

Pageof 2

Frequent Collaborators

4 joint publications

David R Gandara

3 joint publications

Mary W Redman

3 joint publications

Karen L Reckamp

3 joint publications

Karen Kelly